Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) declared a quarterly dividend on Wednesday, February 12th,Wall Street Journal reports. Investors of record on Friday, February 21st will be given a dividend of 0.47 per share on Monday, March 31st. This represents a $1.88 annualized dividend and a dividend yield of 13.67%. The ex-dividend date is Friday, February 21st.
Abrdn Life Sciences Investors Stock Performance
NYSE HQL traded down $0.02 on Wednesday, hitting $13.75. 162,026 shares of the stock were exchanged, compared to its average volume of 129,547. The business’s fifty day moving average is $13.75 and its 200 day moving average is $14.53. Abrdn Life Sciences Investors has a 52 week low of $12.76 and a 52 week high of $15.90.
Insider Activity
In related news, major shareholder Saba Capital Management, L.P. sold 11,674 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $14.12, for a total transaction of $164,836.88. Following the transaction, the insider now directly owns 3,418,349 shares of the company’s stock, valued at approximately $48,267,087.88. The trade was a 0.34 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders have sold 71,650 shares of company stock valued at $1,006,496. 10.06% of the stock is owned by company insiders.
Abrdn Life Sciences Investors Company Profile
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
Read More
- Five stocks we like better than Abrdn Life Sciences Investors
- ETF Screener: Uses and Step-by-Step Guide
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Why Are These Companies Considered Blue Chips?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Canada Bond Market Holiday: How to Invest and Trade
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.